Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

36.29 -0.36 (-0.98%)
Streaming Delayed Price Updated: 9:42 AM EDT, Jul 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,253
Open 36.53
Bid (Size) 35.97 (200)
Ask (Size) 36.60 (100)
Prev. Close 36.65
Today's Range 36.19 - 36.57
52wk Range 21.33 - 40.58
Shares Outstanding 48,390,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit ↗
IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress across the company’s oncology pipeline during a fireside chat at TD Cowen’s seventh annual Oncology Innovation Summit,... 
Via MarketBeat
News headline image
IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing ↗
IDEAYA Biosciences (NASDAQ:IDYA) Chief Executive Yujiro Hata said the precision oncology company is preparing for a busy 2026, led by regulatory and clinical milestones for darovasertib in metastatic... 
Via MarketBeat

Performance

YTD
+7.2%
+7.2%
1 Month
+20.0%
+20.0%
3 Month
+12.2%
+12.2%
6 Month
+3.4%
+3.4%
1 Year
+60.7%
+60.7%

More News

Read More
News headline image
IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data ↗
Via MarketBeat
News headline image
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
From USA News Group
Via GlobeNewswire
News headline image
Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
News headline image
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? ↗
Via The Motley Fool
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
Via Chartmill
News headline image
IDEAYA Biosciences Inc (NASDAQ:IDYA) Shows Strong Technical Setup for Potential Breakout ↗
Via Chartmill
News headline image
SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
Buying IDEAYA Might Be The Wrong IDYA Right Now ↗
Via Benzinga
News headline image
Alibaba To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
IDEAYA (IDYA) Q2 Net Loss Improves 27% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
This Royal Caribbean Cruises Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday ↗
Via Benzinga
News headline image
This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
Via Benzinga
News headline image
This NRG Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
Via Benzinga
News headline image
Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It ↗
Via Benzinga
News headline image
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
From Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Via Business Wire
News headline image
This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
Via Benzinga
News headline image
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate ↗
Via Benzinga
News headline image
Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024 ↗
Via InvestorPlace
News headline image
Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal ↗
Via Talk Markets
News headline image
MarketBeat Week in Review – 7/15 - 7/19
Via MarketBeat
Topics Economy

Frequently Asked Questions

Is IDEAYA Biosciences, Inc. - Common Stock publicly traded?
Yes, IDEAYA Biosciences, Inc. - Common Stock is publicly traded.
What exchange does IDEAYA Biosciences, Inc. - Common Stock trade on?
IDEAYA Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for IDEAYA Biosciences, Inc. - Common Stock?
The ticker symbol for IDEAYA Biosciences, Inc. - Common Stock is IDYA on the Nasdaq Stock Market
What is the current price of IDEAYA Biosciences, Inc. - Common Stock?
The current price of IDEAYA Biosciences, Inc. - Common Stock is 36.29
When was IDEAYA Biosciences, Inc. - Common Stock last traded?
The last trade of IDEAYA Biosciences, Inc. - Common Stock was at 07/15/26 09:42 AM ET
What is the market capitalization of IDEAYA Biosciences, Inc. - Common Stock?
The market capitalization of IDEAYA Biosciences, Inc. - Common Stock is 1.76B
How many shares of IDEAYA Biosciences, Inc. - Common Stock are outstanding?
IDEAYA Biosciences, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.